Other Clinical Trial - Evaluation of Sun Protection Education for Kidney

Status Completed

Clinical Trial Summary

This study is being done to evaluate the effectiveness of a Sun Protection Strategies workbook for kidney transplant recipients. Since the medication taken to preserve the kidney transplant puts kidney transplant recipients at an increased risk of developing skin cancer. The program will help people learn about how to practice effective sun protection after the transplant.

Clinical Trial Description

Cognitive interview about the Sun Protection Strategies workbook will be performed with up to 25 kidney transplant recipients (KTR) who have participated in past surveys. A second phase of the study involves 156 KTRs that will be asked to take part in a randomized controlled trial evaluating the fully developed sun protective strategies workbook.

Kidney transplant recipients (KTRs) are at risk to develop skin cancer. Adequate sun protection after transplantation can reduce the risk of developing skin cancer. In 2006, the National Kidney Foundation (NKF) found that sun protection education delivery and content varied among transplantation centers. Clinicians rarely knew when to initiate education about skin cancer risks and prevention including timing and scope, and rarely demonstrated understanding of the importance of reminders for and repeated education of patients (National Kidney Foundation 2006).

Aims:

1. To explore culturally sensitive use of terms describing ethnic cultural perceptions of sun burning, pigment darkening after sun exposure and description of skin color by the amount of photo-protective pigment in the skin.

2. To pilot test the sun protection workbook with English speaking KTRs representing the 3 ethnic groups: White, Black and Hispanic.

3. To assess the effectiveness of an education intervention encouraging the use of sun protection strategies.

4. To explore understanding of the importance of sun protection and the KTRs confidence in their being able to practice sun protection. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention

Related Conditions & MeSH terms

Disorder Related to Renal Transplantation
Unspecified Complications of Kidney Transplant

Clinical Trial Details

NCT number	NCT01844713
Study type	Interventional
Source	Northwestern University
Contact
Status	Completed
Phase	N/A
Start date	May 2013
Completion date	July 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02581436` - Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR	N/A
Terminated	`NCT01561404` - Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise	Phase 4
Recruiting	`NCT02849899` - Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period	Phase 3
Not yet recruiting	`NCT01289301` - Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant	Phase 4
Completed	`NCT00905957` - Transversus Abdominis Plane Block For Renal Transplant Recipients	N/A
Active, not recruiting	`NCT02843867` - Orientation of the Lymphocyte Response to the Occurrence of Atherosclerotic Complications After Kidney Transplantation
Active, not recruiting	`NCT02751099` - Bone and Cardiovascular Disease After Kidney Transplant
Completed	`NCT01744067` - The Effects of Omega-3 Fatty Acids in Renal Transplantation	Phase 4
Completed	`NCT01646099` - Sun Protection of Kidney Transplant Recipients	N/A
Active, not recruiting	`NCT03935958` - Curcumin in Kidney Transplant Recipients	N/A
Recruiting	`NCT02513602` - Osseointegrated Dental Implants in Kidney Transplanted Patients	N/A
Recruiting	`NCT01550445` - Steroid Withdrawal Immunosuppression After Renal Transplantation	Phase 4
Completed	`NCT02540395` - Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation	N/A
Completed	`NCT01195194` - Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity.	Phase 4
Completed	`NCT00724022` - Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation	Phase 4
Terminated	`NCT00167661` - Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation	Phase 1/Phase 2
Completed	`NCT03968588` - Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation	Phase 4
Recruiting	`NCT02515643` - Contribution of Renal Function to Endothelial Dysfunction in Living Kidney Donors and Transplant Recipients	N/A
Completed	`NCT00455013` - A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation	Phase 2
Recruiting	`NCT02843763` - Study of Specific CD4 Tumors Th1 Responses in Renal Transplant After Occurrence of Cancer	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of Sun Protection Education for Kidney Transplant Recipients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms